Cargando…
Aggravation of retinal hard exudates after intravitreal anti-vascular endothelial growth factor therapy for cystoid macular edema and the risk factors: a retrospective study
BACKGROUND/AIMS: To evaluate retinal hard exudates (HEs) progression in patients with cystoid macular edema (CME) secondary to diabetic retinopathy (DR) or branch retinal vascular occlusion (BRVO) after intravitreal injections of ranibizumab (IVR) treatment and identify the risk factors for the dete...
Autores principales: | Shi, Rui, Guo, Zhonglan, Yang, Xiangxiang, Che, Xuanyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867860/ https://www.ncbi.nlm.nih.gov/pubmed/35197011 http://dx.doi.org/10.1186/s12886-022-02315-z |
Ejemplares similares
-
Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon, Sohee, et al.
Publicado: (2014) -
Intravitreal Diclofenac for Refractory Uveitic Cystoid Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2013) -
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
por: Yoon, Chang Ki, et al.
Publicado: (2021) -
Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
por: Kakkassery, Vinodh, et al.
Publicado: (2017) -
Intravitreal and Subtenon Depot Triamcinolone as Treatment of Retinitis Pigmentosa Associated Cystoid Macular Edema
por: Barge, Sidnei, et al.
Publicado: (2013)